Literature DB >> 26577910

Paravertebral regional blocks decrease length of stay following surgery for pectus excavatum in children.

Patrick D Loftus1, Craig T Elder1, Katie W Russell1, Stephen P Spanos2, Douglas C Barnhart1, Eric R Scaife1, David E Skarda1, Michael D Rollins1, Rebecka L Meyers3.   

Abstract

PURPOSE: Management of postoperative pain following repair of pectus excavatum has traditionally included thoracic epidural analgesia, narcotics, and benzodiazepines. We hypothesized that the use of intercostal or paravertebral regional blocks could result in decreased inpatient length of stay (LOS).
METHODS: We conducted a retrospective cohort study of 137 patients (118 Nuss and 19 Ravitch - Nuss and Ravitch patients were analyzed separately) who underwent surgical repair of pectus excavatum with pain management via epidural, intercostal, or paravertebral analgesia from January 2009-December 2012. Measured outcomes included LOS, pain scores, benzodiazepine/narcotic requirements, emesis, professional fees, hospital cost, and total cost.
RESULTS: In the Nuss patients, LOS was significantly reduced in the paravertebral group (p<0.005) and the intercostal group (p<0.005) compared to the epidural group, but was paradoxically countered by a nonsignificant increase in total cost (p=0.09). While benzodiazepine doses/day was not increased in the paravertebral group (p=0.08), an increase was seen in narcotic use (p<0.005). Despite increased narcotic use, no differences were seen in emesis between epidural and paravertebral use. Compared to epidural, pain scores were higher for both intercostal and paravertebral on day one (p<0.005), but equivalent for paravertebral on day three (p=0.62). The Ravitch group was too small for detailed independent statistical analysis but followed the same overall trend seen in the Nuss patients.
CONCLUSION: Our use of paravertebral continuous infusion pain catheters for pectus excavatum repair was an effective alternative to epidural analgesia resulting in shorter LOS but not a decrease in overall cost.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidural; Intercostal; Length of stay; Pain management; Paravertebral; Pectus excavatum

Mesh:

Substances:

Year:  2015        PMID: 26577910     DOI: 10.1016/j.jpedsurg.2015.10.037

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

Review 1.  Paediatric regional anaesthesia: updates in central neuraxial techniques and thoracic and abdominal blocks.

Authors:  D Greaney; T Everett
Journal:  BJA Educ       Date:  2019-02-15

2.  Letter to the Editor: Early Consequences of Pectus Excavatum Surgery on Self-Esteem and General Quality of Life.

Authors:  Curtis Darling; Stephanie Chao; Radhamangalm Ramamurthi; Ban Tsui
Journal:  World J Surg       Date:  2019-03       Impact factor: 3.352

3.  Author's Reply: Early Consequences of Pectus Excavatum Surgery on Self-Esteem and General Quality of Life.

Authors:  Wietse P Zuidema
Journal:  World J Surg       Date:  2019-03       Impact factor: 3.352

4.  Intraoperative intercostal nerve cryoablation During the Nuss procedure reduces length of stay and opioid requirement: A randomized clinical trial.

Authors:  Claire E Graves; Jarrett Moyer; Michael J Zobel; Roberto Mora; Derek Smith; Maura O'Day; Benjamin E Padilla
Journal:  J Pediatr Surg       Date:  2019-03-17       Impact factor: 2.545

5.  Implementation of an Enhanced Recovery Pathway for Minimally Invasive Pectus Surgery: A Population-Based Cohort Study Evaluating Short- and Long-Term Outcomes Using eHealth Technology.

Authors:  Davina Wildemeersch; Michiel D'Hondt; Lisa Bernaerts; Pieter Mertens; Vera Saldien; Jeroen Mh Hendriks; Anne-Sophie Walcarius; Lutgard Sterkens; Guy H Hans
Journal:  JMIR Perioper Med       Date:  2018-10-12

6.  Intravenous Morphine Infusion versus Thoracic Epidural Infusion of Ropivacaine with Fentanyl after the Ravitch Procedure-A Single-Center Cohort Study.

Authors:  Dariusz Fenikowski; Lucyna Tomaszek
Journal:  Int J Environ Res Public Health       Date:  2022-09-08       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.